We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Allergan Must Face FCA Suit Over Drug Samples, Rx Pads

Law360, New York (April 3, 2017, 8:15 PM EDT) -- A New York federal judge largely upheld a whistleblower’s False Claims Act suit accusing Allergan Inc. of bribing doctors to prescribe eye care products by providing drug samples and prescription pads, and then wrongly firing the former employee, dismissing only some state claims.

In an 89-page ruling, U.S. District Judge Jesse M. Furman said the suit wasn’t barred by the FCA's public disclosure or first-to-file bar, even though similar litigation had been brought before, and said the suit meets the FCA’s standards. John Wood filed the...
To view the full article, register now.




Case Information

Case Title


Case Number



New York Southern

Nature of Suit

Qui Tam (31 U.S.C. & Sect; 3729(a))


Jesse M. Furman

Date Filed

July 26, 2010

Law Firms


Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.